President Donald Trump has called on 17 pharmaceutical companies to implement most-favored-nation drug pricing in the next 60 days.

A new FDA program will use a two-phase approach to help boost domestic drug manufacturing, while OpenAI is leaning into health care with the launch of GPT-5.

More than five years after the Covid-19 pandemic first ravaged the nation, many Americans are still dealing with the social ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

GE Appliances plans to create 1,000 new jobs across Kentucky, Alabama, Georgia, Tennessee and South Carolina facilities as part of major expansion initiative ...

Insmed received FDA clearance for the first treatment for a chronic lung disease, opening the way to what could be a ...

Tariff revenue: The Treasury also reported that Trump’s tariffs brought in $27.7 billion in revenue in July, less than 10% of ...

If Novo Nordisk A/S’s wildly popular weight-loss drug succeeds in a highly anticipated trial for Alzheimer’s disease, Biogen Inc.’s Chief Executive Officer Chris Viehbacher doesn’t see it as a ...

Pharmaceutical company AbbVie announced Tuesday that it will construct a new $195 million facility near its headquarters in ...

Paxton says he wants O'Rourke in jail for his fundraising efforts on behalf of Texas Democrats who have stymied GOP plans to ...

The gush of second quarter earnings reports is beginning to slow to a trickle, and with most of the reports in, the results ...

Former U.S. Sen. Sherrod Brown, Ohio’s best-known Democrat, is expected to make another run for the Senate next year as ...